Ginkgo Bioworks Holdings, Inc.

DNANYSE • USD
12.35 USD
↘ 0.15 (1.20%)AT CLOSE (03:59 PM EDT)
12.32
↘ 0.04 (0.28%)
POST MARKET (AS OF 08:14 PM EDT)
Post Market
AS OF 08:14 PM EDT
12.32
↘ 0.04 (0.28%)
🔴Market: CLOSED

DNA is currently priced at $12.35. DNA shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. DNA is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Oct 2, 2026.

Open?$13.00
High?$13.40
Low?$11.94
Prev. Close?$12.50
Volume?2.0M
Avg. Volume?1.8M
VWAP?$12.45
Rel. Volume?1.15x
Bid / Ask
Bid?$12.28 × 100
Ask?$12.50 × 100
Spread?$0.22
Midpoint?$12.39
Valuation & Ratios
Market Cap?831.7M
Shares Out?55.4M
Float?42.4M
Float %?76.6%
P/E Ratio?N/A
P/B Ratio?1.98
EPS?-$4.32
Dividend?0.00%
Ex-Dividend?N/A
RelatedTWST
News
Profile
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
Employees
485
Market Cap
831.7M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2021-04-19
Address
27 DRYDOCK AVENUE
BOSTON, MA 02210
Phone: (877) 442-5362
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
0
Momentum?
55
Short Sent.?
45
Piotroski F-Score?1/9Weak
Altman Z-Score?-8.57Distress
Confidence?61%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?16.89%High
Short Interest?7.2M
Days to Cover?7.2
Free Float42.4M
Avg Daily Volume994.8K
Settlement Date2026-09-15
Financial Health
Current Ratio?4.57Strong
Quick Ratio?4.57Strong
Cash Ratio?1.16Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
74
1.98CHEAP▾
P/S?
Peers
100
S&P
15
7.43HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-3.1CHEAP▾
EV/Sales?
Peers
100
S&P
22
6.68HIGH▾
Returns & Efficiency
ROE?
S&P
3
-69.2%WEAK▾
ROA?
S&P
3
-29.4%WEAK▾
Cash Flow & Enterprise
FCF?$-174800000
Enterprise Value?$747.1M
Fundamentals ratios updated end of day